Imaging of VEGF receptor in a rat myocardial infarction model using PET

Journal of Nuclear Medicine

Volumn 49, Issue 4, 2008, Pages 667-673

  Rodriguez Porcel, Martin ^a,b   Cai, Weibo ^a   Gheysens, Olivier ^a   Willmann, Jürgen K ^a   Chen, Kai ^a   Wang, Hui ^a   Chen, Ian Y ^a,c   He, Lina ^a   Wu, Joseph C ^a,d   Li, Zi Bo ^a   Mohamedali, Khalid A ^e   Kim, Sehoon ^e   Rosenblum, Michael G ^e   Chen, Xiaoyuan ^a   Gambhir, Sanjiv Sam ^a,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Mayo Clinic   (United States)

^c Stanford University   (United States)

^d STANFORD UNIVERSITY   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

64Cu; Angiogenesis; Myocardial infarction; PET; Vascular endothelial growth factor (VEGF); VEGF receptor (VEGFR)

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID VASCULOTROPIN 121 CU 64; FLUORODEOXYGLUCOSE F 18; TRACER; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; FEMALE; HEART INFARCTION; LEFT CORONARY ARTERY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ULTRASOUND;

ANIMALS; COPPER RADIOISOTOPES; DISEASE MODELS, ANIMAL; FEMALE; ISOTOPE LABELING; MYOCARDIAL INFARCTION; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;

EID: 42049103246     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.040576     Document Type: Article

References (33)

1. Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol. 1996;270:H1803-H1811.
2. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med. 2000;342:626-633.
3. Ferrara N. The role of VEGF in the regulation of physiological and pathological angiogenesis. EXS. 2005:200-231.
4. McColl BK, Stacker SA, Achen MG. Molecular regulation of the VEGF family: inducers of angiogenesis and lymphangiogenesis. APMIS. 2004;112:463-480.
5. McMahon G. VEGF receptor signaling in tumor angiogenesis. Oncologist. 2000;5(suppl 1):3-10.
6. Goodsell DS. The molecular perspective: VEGF and angiogenesis. Oncologist. 2002;7:569-570.
7. LeCouter J, Lin R, Ferrara N. The role of EG-VEGF in the regulation of angio-genesis in endocrine glands. Cold Spring Harb Symp Quant Biol. 2002;67:217-221.
8. Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology. 2005;69(suppl 3):4-10.
9. Shinohara K, Shinohara T, Mochizuki N, et al. Expression of vascular endothelial growth factor in human myocardial infarction. Heart Vessels. 1996;11:113-122.
10. Wu JC, Tseng JR, Gambhir SS. Molecular imaging of cardiovascular gene products. J Nucl Cardiol. 2004;11:491-505.
11. Herschman HR, MacLaren DC, Iyer M, et al. Seeing is believing: non-invasive, quantitative and repetitive imaging of reporter gene expression in living animals, using positron emission tomography. J Neurosci Res. 2000;59:699-705.
12. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 2003;17:545-580.
13. Su H, Spinale FG, Dobrucki LW, et al. Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling. Circulation. 2005;112:3157-3167.
14. Chen J, Tung CH, Allport JR, Chen S, Weissleder R, Huang PL. Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction. Circulation. 2005;111:1800-1805.
15. Meoli DF, Sadeghi MM, Krassilnikova S, et al. Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J Clin Invest. 2004;113:1684-1691.
16. Lu E, Wagner WR, Schellenberger U, et al. Targeted in vivo labeling of receptors for vascular endothelial growth factor: approach to identification of ischemic tissue. Circulation. 2003;108:97-103.
17. Cai W, Chen K, Mohamedali KA, et al. PET of vascular endothelial growth factor receptor expression. J Nucl Med. 2006;47:2048-2056.
18. National Institutes of Health. Guide for the Care and Use of Laboratory Animals. 1996. Available at: http://www.nap.edu/catalog.php? record_id=5140. Accessed February 17, 2008.
19. Wu JC, Chen IY, Wang Y, et al. Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium. Circulation. 2004;110:685-691.
20. Rodriguez-Porcel M, Gheysens O, Chen IY, Wu JC, Gambhir SS. Image-guided cardiac cell delivery using high-resolution small-animal ultrasound. Mol Ther. 2005;12:1142-1147.
21. Chen X, Plasencia C, Hou Y, Neamati N. Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery. J Med Chem. 2005;48:1098-1106.
22. 18F-FRGD2. J Nucl Med. 2006;47:113-121.
23. 18F]FDG synthesis by alkaline hydrolysis on a low polarity solid phase support. J Labelled Compds Radiopharm. 2002;45:435-447.
24. Wu JC, Chen IY, Sundaresan G, et al. Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation. 2003;108:1302-1305.
25. Su H, Forbes A, Gambhir SS, Braun J. Quantitation of cell number by a positron emission tomography reporter gene strategy. Mol Imaging Biol. 2004;6:139-148.
26. Loening AM, Gambhir SS. AMIDE: a free software tool for multimodality medical image analysis. Mol Imaging. 2003;2:131-137.
27. Schroter G, Schneider-Eicke J, Schwaiger M. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging. Herz. 1994;19:42-50.
28. Ghesani M, Depuey EG, Rozanski A. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability. Echocardiography. 2005;22:165-177.
29. Wang H, Cai W, Chen K, et al. A new PET tracer specific for vascular endothelial growth factor receptor 2. Eur J Nucl Med Mol Imaging. 2007;34:2001-2010.
30. Ren G, Dewald O, Frangogiannis NG. Inflammatory mechanisms in myocardial infarction. Curr Drug Targets Inflamm Allergy. 2003;2:242-256.
31. Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res. 2004;94:1543-1553.
32. 64Cu-labeled tetrameric RGD peptide. J Nucl Med. 2005;46:1707-1718.
33. Thim T, Bentzon JF, Kristiansen SB, et al. Size of myocardial infarction induced by ischaemia/reperfusion is unaltered in rats with metabolic syndrome. Clin Sci (Lond). 2006;110:665-671.